These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 9767399

  • 1. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA, Lee CS, Björklund A.
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [Abstract] [Full Text] [Related]

  • 2. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA, Andersson M, Andersson KE, Cenci MA.
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [Abstract] [Full Text] [Related]

  • 3. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 4. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 5. Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulata.
    Carta AR, Tabrizi MA, Baraldi PG, Pinna A, Pala P, Morelli M.
    Exp Neurol; 2003 Dec; 184(2):679-87. PubMed ID: 14769359
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
    Carta AR, Pinna A, Cauli O, Morelli M.
    Synapse; 2002 Jun 01; 44(3):166-74. PubMed ID: 11954048
    [Abstract] [Full Text] [Related]

  • 7. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N, Martín AB, Mendialdua A, Moratalla R.
    Biol Psychiatry; 2006 Jan 01; 59(1):64-74. PubMed ID: 16139809
    [Abstract] [Full Text] [Related]

  • 8. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.
    Neuropharmacology; 2010 Jan 01; 58(1):286-96. PubMed ID: 19576910
    [Abstract] [Full Text] [Related]

  • 9. Systemic administration of dizocilpine maleate (MK-801) or L-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model.
    Bacci JJ, Salin P, Kerkerian-Le Goff L.
    Synapse; 2002 Dec 15; 46(4):224-34. PubMed ID: 12373737
    [Abstract] [Full Text] [Related]

  • 10. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV, Groenewegen HJ, Voorn P.
    Synapse; 2002 Jan 15; 43(1):1-11. PubMed ID: 11746728
    [Abstract] [Full Text] [Related]

  • 11. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
    Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA.
    J Neurochem; 2006 Mar 15; 96(6):1718-27. PubMed ID: 16539687
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP, Fox SH, Johnston T, Reyes G, Millan MJ, Brotchie JM.
    Neurobiol Dis; 2009 Aug 15; 35(2):184-92. PubMed ID: 19118628
    [Abstract] [Full Text] [Related]

  • 13. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.
    Carta AR, Tronci E, Pinna A, Morelli M.
    Eur J Neurosci; 2005 Mar 15; 21(5):1196-204. PubMed ID: 15813929
    [Abstract] [Full Text] [Related]

  • 14. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.
    Andersson M, Hilbertson A, Cenci MA.
    Neurobiol Dis; 1999 Dec 15; 6(6):461-74. PubMed ID: 10600402
    [Abstract] [Full Text] [Related]

  • 15. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
    Winkler C, Kirik D, Björklund A, Cenci MA.
    Neurobiol Dis; 2002 Jul 15; 10(2):165-86. PubMed ID: 12127155
    [Abstract] [Full Text] [Related]

  • 16. Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.
    Pirker W, Tedroff J, Pontén H, Gunne L, Andrén PE, Hurd YL.
    Exp Neurol; 2001 May 15; 169(1):122-34. PubMed ID: 11312565
    [Abstract] [Full Text] [Related]

  • 17. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA.
    Neurobiol Dis; 2011 Jun 15; 42(3):327-40. PubMed ID: 21310234
    [Abstract] [Full Text] [Related]

  • 18. Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.
    Guan Q, Zhan Q, He Y, Tan L.
    Neurosci Lett; 2007 Oct 09; 426(1):64-8. PubMed ID: 17884291
    [Abstract] [Full Text] [Related]

  • 19. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
    Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA.
    J Neurochem; 2010 Mar 09; 112(6):1465-76. PubMed ID: 20050978
    [Abstract] [Full Text] [Related]

  • 20. Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.
    Sgroi S, Capper-Loup C, Paganetti P, Kaelin-Lang A.
    Exp Neurol; 2016 Jun 09; 280():80-8. PubMed ID: 27072528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.